QQ客服 官方微博 反馈留言

	Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors
	Zhang, Zhen; Zhang, Daoguang; Liu, Yang; Yang, Dezhi; Ran, Fansheng; Wang, Michael L.; Zhao, Guisen
刊名	ARCHIV DER PHARMAZIE
	2018
卷号	351期号:7
关键词	arthritis Bruton's tyrosine kinase BTK inhibitor leukemia lymphoma
DOI	10.1002/ardp.201700369
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4579165
专题	山东大学
作者单位	Shandong Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Chem Biol,Dept Med Ch
推荐引用方式 GB/T 7714	Zhang, Zhen,Zhang, Daoguang,Liu, Yang,et al. Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors[J]. ARCHIV DER PHARMAZIE,2018,351(7).
APA	Zhang, Zhen.,Zhang, Daoguang.,Liu, Yang.,Yang, Dezhi.,Ran, Fansheng.,...&Zhao, Guisen.(2018).Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors.ARCHIV DER PHARMAZIE,351(7).
MLA	Zhang, Zhen,et al."Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors".ARCHIV DER PHARMAZIE 351.7(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。